| abstract |
The present invention relates to a 1,3,8-substituted xanthine derivative represented by formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , and R 3 are defined in the specification. As it was). Compounds of formula (I) and pharmaceutically acceptable salts or prodrugs thereof show an effect as a modulator of gluconeogenesis. |